Zingg, D., Arenas-Ramirez, N., Sahin, D., Rosalia, R. A., Antunes, A. T., Haeusel, J., . . . Boyman, O. (2017). The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy. Cell reports (Cambridge), 20(4), 854-867. https://doi.org/10.1016/j.celrep.2017.07.007
Chicago Style (17th ed.) CitationZingg, Daniel, Natalia Arenas-Ramirez, Dilara Sahin, Rodney A. Rosalia, Ana T. Antunes, Jessica Haeusel, Lukas Sommer, and Onur Boyman. "The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy." Cell Reports (Cambridge) 20, no. 4 (2017): 854-867. https://doi.org/10.1016/j.celrep.2017.07.007.
MLA (9th ed.) CitationZingg, Daniel, et al. "The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy." Cell Reports (Cambridge), vol. 20, no. 4, 2017, pp. 854-867, https://doi.org/10.1016/j.celrep.2017.07.007.